This suggests that GLP-1RAs may modify the inflammatory cascade of osteoarthritis (OA) by modifying the secretion of cytokines and tumor necrosis factor-α (TNF-α), the pro-inflammatory molecules that are produced by macrophages responsible cartilage degradation and synovial inflammation. Here, TNF is linked to osteoarthritis.